FULLER & THALER ASSET MANAGEMENT, INC. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 220 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 4.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
FULLER & THALER ASSET MANAGEMENT, INC. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$6,891,000
-13.3%
438,342
-0.4%
0.08%
-21.9%
Q4 2017$7,952,000
+184.0%
440,300
+203.4%
0.10%
+182.4%
Q3 2017$2,800,000
+328.1%
145,100
+161.9%
0.03%
+277.8%
Q2 2017$654,000
+7.7%
55,4000.0%0.01%
+12.5%
Q1 2017$607,000
+87.3%
55,400
+24.2%
0.01%
+60.0%
Q4 2016$324,000
+489.1%
44,600
+424.7%
0.01%
+400.0%
Q3 2016$55,0008,5000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders